1. Home
  2. LAKE vs FATE Comparison

LAKE vs FATE Comparison

Compare LAKE & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakeland Industries Inc.

LAKE

Lakeland Industries Inc.

HOLD

Current Price

$11.24

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$2.42

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAKE
FATE
Founded
1982
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
122.0M
125.6M
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
LAKE
FATE
Price
$11.24
$2.42
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$15.33
$4.10
AVG Volume (30 Days)
52.5K
1.8M
Earning Date
04-16-2026
05-14-2026
Dividend Yield
0.92%
N/A
EPS Growth
N/A
29.88
EPS
0.04
N/A
Revenue
$192,648,000.00
$6,646,000.00
Revenue This Year
$10.88
N/A
Revenue Next Year
$10.71
N/A
P/E Ratio
$281.25
N/A
Revenue Growth
15.21
N/A
52 Week Low
$7.15
$0.93
52 Week High
$18.00
$3.23

Technical Indicators

Market Signals
Indicator
LAKE
FATE
Relative Strength Index (RSI) 45.42 44.20
Support Level $10.46 $2.25
Resistance Level $11.55 $2.88
Average True Range (ATR) 0.50 0.18
MACD -0.11 -0.03
Stochastic Oscillator 16.47 27.69

Price Performance

Historical Comparison
LAKE
FATE

About LAKE Lakeland Industries Inc.

Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe, and Other Foreign. It generates the majority of its revenue from the United States.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: